Cargando…

Role of FXR in Renal Physiology and Kidney Diseases

Farnesoid X receptor, also known as the bile acid receptor, belongs to the nuclear receptor (NR) superfamily of ligand-regulated transcription factors, which performs its functions by regulating the transcription of target genes. FXR is highly expressed in the liver, small intestine, kidney and adre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Yanlin, Xie, Guixiang, Zhang, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916923/ https://www.ncbi.nlm.nih.gov/pubmed/36768731 http://dx.doi.org/10.3390/ijms24032408

Ejemplares similares

Bile acid receptors and renal regulation of water homeostasis
por: Guo, Yanlin, et al.
Publicado: (2023)

Fatty liver diseases, bile acids, and FXR
por: Zhu, Yan, et al.
Publicado: (2016)

FXR and NASH: an avenue for tissue-specific regulation
por: Henry, Zakiyah, et al.
Publicado: (2023)

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
por: Nijmeijer, Rian M., et al.
Publicado: (2011)

Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
por: Xiang, Junwei, et al.
Publicado: (2021)

Farnesoid X receptor (FXR): Structures and ligands
por: Jiang, Longying, et al.
Publicado: (2021)

Bile acid nuclear receptor FXR and digestive system diseases
por: Ding, Lili, et al.
Publicado: (2015)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
por: Qiu, Yuxiang, et al.
Publicado: (2023)

Bile Acids and FXR: Novel Targets for Liver Diseases
por: Stofan, Mary, et al.
Publicado: (2020)

FXR an emerging therapeutic target for the treatment of atherosclerosis
por: Mencarelli, Andrea, et al.
Publicado: (2010)

Update on FXR Biology: Promising Therapeutic Target?
por: Han, Chang Yeob
Publicado: (2018)

Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
por: Jin, Lihua, et al.
Publicado: (2015)

Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease
por: Chua, Janice T., et al.
Publicado: (2019)

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019)

Deciphering the nuclear bile acid receptor FXR paradigm
por: Modica, Salvatore, et al.
Publicado: (2010)

SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR
por: Cui, Shuang, et al.
Publicado: (2023)

Reconstruction of FXR Beam Conditions
por: Nexsen, W E, et al.
Publicado: (2001)

FXR expression in rats of hilar cholangiocarcinoma
por: Zhang, Meng-yu, et al.
Publicado: (2022)

Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
por: Zhao, Kai, et al.
Publicado: (2016)

Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery
por: Noel, Olivier F., et al.
Publicado: (2016)

FXR Friend-ChIPs in the Enterohepatic System
por: Meadows, Vik, et al.
Publicado: (2023)

Proteomics for the discovery of nuclear bile acid receptor FXR targets()
por: Gardmo, Cissi, et al.
Publicado: (2011)

Secondary (iso)BAs cooperate with endogenous ligands to activate FXR under physiological and pathological conditions
por: Zaufel, Alex, et al.
Publicado: (2021)

Structural Studies of the Tandem Tudor Domains of Fragile X Mental Retardation Related Proteins FXR1 and FXR2
por: Adams-Cioaba, Melanie A., et al.
Publicado: (2010)

Regulon analysis identifies protective FXR and CREB5 in proximal tubules in early diabetic kidney disease
por: Shi, Wanting, et al.
Publicado: (2023)

Liver Capsule: FXR agonists against liver disease
por: Fuchs, Claudia D., et al.
Publicado: (2016)

The Gut Microbiota as a Therapeutic Target in IBD and Metabolic Disease: A Role for the Bile Acid Receptors FXR and TGR5
por: Baars, Annemarie, et al.
Publicado: (2015)

The Role of G-Protein-Coupled Receptor Proteolysis Site Cleavage of Polycystin-1 in Renal Physiology and Polycystic Kidney Disease
por: Trudel, Marie, et al.
Publicado: (2016)

From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases
por: Zhang, Lingge, et al.
Publicado: (2023)

FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity
por: Glastras, Sarah J., et al.
Publicado: (2015)

FXR controls CHOP expression in steatohepatitis
por: Fuchs, Claudia D., et al.
Publicado: (2017)

FXR induces SOCS3 and suppresses hepatocellular carcinoma
por: Guo, Fei, et al.
Publicado: (2015)

Harnessing the Physiological Functions of Cellular Prion Protein in the Kidneys: Applications for Treating Renal Diseases
por: Yoon, Sungtae, et al.
Publicado: (2021)

Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis
por: Nijmeijer, Rian M., et al.
Publicado: (2014)

FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion
por: Fan, Yichao, et al.
Publicado: (2017)

The Role of the Nuclear Receptor FXR in Arsenic-Induced Glucose Intolerance in Mice
por: Yang, Yifei, et al.
Publicado: (2023)

The roles of hydrogen sulfide in renal physiology and disease states
por: Feng, Jianan, et al.
Publicado: (2022)

Effects of high altitude on renal physiology and kidney diseases
por: Wang, Si-Yang, et al.
Publicado: (2022)

Genome-wide profiling to analyze the effects of FXR activation on mouse renal proximal tubular cells
por: Gui, Ting, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e1fr7l4al34sfbch7ikorh2och